These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21179748)

  • 1. [Progress in prevention and treatment of liver precancerous lesions].
    Zhang LL; Wang L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Sep; 30(9):1003-8. PubMed ID: 21179748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress of diagnosis and treatment of precancerous pathological lesions of mammary cancer].
    Song AL; Liu XF; Li JW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Feb; 26(2):188-90. PubMed ID: 16548366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Integrated traditional Chinese medicine and Western medicine in the prevention and treatment of malignant tumor in 21st century].
    Yu G; Liang F; Zhang D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Jul; 19(7):423-5. PubMed ID: 11783219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sho-saiko-to].
    Oka H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():774-8. PubMed ID: 11762055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in research on the treatment of primary liver cancer with traditional Chinese medicine for activating blood to resolve stasis].
    Ju LX; Chen Z; Ren RZ
    Zhong Xi Yi Jie He Xue Bao; 2005 Nov; 3(6):491-4. PubMed ID: 16282066
    [No Abstract]   [Full Text] [Related]  

  • 6. Saffron offers protection from liver cancer.
    Harrington M
    Lab Anim (NY); 2011 Sep; 40(10):289. PubMed ID: 22358197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic study of gastric precancerous condition].
    Hu L; Lao S; Chen W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Jun; 19(6):372-3. PubMed ID: 11783204
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationship of the dual nature of effect of cancer and precancerous lesion treatment by activating blood circulation to remove stasis and the angiogenesis].
    Fan GQ; Song XL; Wang H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):624-6. PubMed ID: 14503069
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of zilongjin on immunologic function of patients with hepatocarcinoma in perioperative stage].
    Li Q; Wu Q; Li HK; Cui YL; Gao CT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Feb; 25(2):163-4. PubMed ID: 15768885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Exploration of reversion and Chinese medical treatment of precancerous lesion of gastric cancer].
    Wang P; Tang XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1305-8. PubMed ID: 24432668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in studies on anti-hepatoma effect of traditional Chinese medicine by adjusting immune function].
    Yang JX; Wang XM
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):281-4. PubMed ID: 17455456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in TCM treatment of primary hepatocarcinoma.
    Guan D; Fang Z
    J Tradit Chin Med; 2000 Sep; 20(3):223-6. PubMed ID: 11038988
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
    Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H
    J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
    Ting CT; Li WC; Chen CY; Tsai TH
    J Chin Med Assoc; 2015 Mar; 78(3):139-44. PubMed ID: 25447209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C].
    Tarao K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():769-73. PubMed ID: 11762054
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Yamazaki M; Tsujinoue H; Imazu H; Fukui H
    Oncol Rep; 2003; 10(4):957-62. PubMed ID: 12792752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the researches on the blocking effect of Chinese drugs on tumors.
    Wu W; Yu E
    J Tradit Chin Med; 2001 Sep; 21(3):236-40. PubMed ID: 11789336
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of gan fu le in interventional treatment of hepatocarcinoma.
    Xu K; Li Z; Zhu D
    J Tradit Chin Med; 2000 Sep; 20(3):185-6. PubMed ID: 11038979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Chinese herbal medicine on patients with primary hepatic carcinoma in III stage during perioperational period: a report of 42 cases].
    Chen LW; Lin J; Chen W; Zhang W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):832-4. PubMed ID: 16250104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "And what other medications are you taking?".
    Gordan JD; Chay WY; Kelley RK; Ko AH; Choo SP; Venook AP
    J Clin Oncol; 2011 Apr; 29(11):e288-91. PubMed ID: 21245436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.